Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (13)

2024

  1. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

2023

  1. Population-based survey on menopausal symptoms and treatment use

    Climacteric, Vol. 26, Núm. 1, pp. 47-54

2021

  1. Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement

    Maturitas, Vol. 144, pp. 4-10

2018

  1. Adherence to SEGO recommendations on heavy menstrual bleeding (SMA-UR study)

    Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 2, pp. 132-138

  2. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 228, pp. 221-224

2015

  1. Revisión: Actualización en el diagnóstico del sangrado menstrual abundante

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 32, Núm. 3, pp. 18-26

  2. Revisión: Actualización en el tratamiento del sangrado menstrual abundante

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 32, Núm. 3, pp. 27-35

2012

  1. Continuation rate of combined hormonal contraception: A prospective multicenter study

    Journal of Women's Health, Vol. 21, Núm. 5, pp. 490-495

  2. Preoperative diagnosis of a breast hydatid cyst using fine-needle aspiration cytology: A case report and review of the literature

    Journal of Medical Case Reports, Vol. 6

2009

  1. Posicionamiento de la Asociación Española para el Estudio de la Menopausia sobre el uso clínico de la Cimicífuga racemosa en el climaterio

    Progresos de Obstetricia y Ginecologia, Vol. 52, Núm. 12, pp. 712-721

2008

  1. Self-described impact of noncompliance among users of a combined hormonal contraceptive method

    Contraception, Vol. 77, Núm. 4, pp. 276-282

  2. The use of isoflavones during climaterium: Position statement of the Spanish Menopause Society

    Progresos en Obstetricia y Ginecologia, Vol. 51, Núm. 3, pp. 146-161

2007

  1. Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study

    Contraception, Vol. 76, Núm. 2, pp. 77-83